Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edgar Meinl

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Journal of the Neurological Sciences|December 31, 2011
Untapped targets in multiple sclerosisEdgar Meinl
Current Opinion in Immunology|July 30, 2021
Endogenous soluble receptors sBCMA and sTACI: biomarker, immunoregulator and hurdle for therapy in multiple myelomaEdgar Meinl, Markus Krumbholz
Seminars in Immunopathology|May 17, 2014
B cells in MS and NMO: pathogenesis and therapyMarkus Krumbholz, Edgar Meinl
Methods in Molecular Biology (Clifton, N.J.)|March 28, 2015
Detection of Autoantibodies Against Myelin Oligodendrocyte Glycoprotein in Multiple Sclerosis and Related DiseasesMelania Spadaro, Edgar Meinl
Current Opinion in Neurology|April 11, 2012
Identifying autoantigens in demyelinating diseases: valuable clues to diagnosis and treatment?Tobias Derfuss, Edgar Meinl
Therapeutic Advances in Neurological Disorders|May 17, 2012
Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and moreMarie Cathrin Mayer, Edgar Meinl
The Journal of Biological Chemistry|August 30, 2020
To cut or not to cut: New rules for proteolytic shedding of membrane proteinsStefan F Lichtenthaler, Edgar Meinl
Annals of Neurology|May 24, 2006
B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulationEdgar Meinl, Markus Krumbholz, Reinhard Hohlfeld
Seminars in Immunopathology|September 19, 2009
Novel approaches for identifying target antigens of autoreactive human B and T cellsKlaus Dornmair, Edgar Meinl, Reinhard Hohlfeld
Trends in Immunology|February 6, 2007
Astrocytes are active players in cerebral innate immunityCinthia Farina, Francesca Aloisi, Edgar Meinl
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Journal of the Neurological Sciences|December 31, 2011
Untapped targets in multiple sclerosisEdgar Meinl
Current Opinion in Immunology|July 30, 2021
Endogenous soluble receptors sBCMA and sTACI: biomarker, immunoregulator and hurdle for therapy in multiple myelomaEdgar Meinl, Markus Krumbholz
Seminars in Immunopathology|May 17, 2014
B cells in MS and NMO: pathogenesis and therapyMarkus Krumbholz, Edgar Meinl
Methods in Molecular Biology (Clifton, N.J.)|March 28, 2015
Detection of Autoantibodies Against Myelin Oligodendrocyte Glycoprotein in Multiple Sclerosis and Related DiseasesMelania Spadaro, Edgar Meinl
Current Opinion in Neurology|April 11, 2012
Identifying autoantigens in demyelinating diseases: valuable clues to diagnosis and treatment?Tobias Derfuss, Edgar Meinl
Therapeutic Advances in Neurological Disorders|May 17, 2012
Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and moreMarie Cathrin Mayer, Edgar Meinl
The Journal of Biological Chemistry|August 30, 2020
To cut or not to cut: New rules for proteolytic shedding of membrane proteinsStefan F Lichtenthaler, Edgar Meinl
Annals of Neurology|May 24, 2006
B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulationEdgar Meinl, Markus Krumbholz, Reinhard Hohlfeld
Seminars in Immunopathology|September 19, 2009
Novel approaches for identifying target antigens of autoreactive human B and T cellsKlaus Dornmair, Edgar Meinl, Reinhard Hohlfeld
Trends in Immunology|February 6, 2007
Astrocytes are active players in cerebral innate immunityCinthia Farina, Francesca Aloisi, Edgar Meinl
Pageof 12